Igc Pharma Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Igc Pharma Inc 's ROA in the second quarter of 2026?
Igc Pharma Inc recorded a cumulative net loss of $-9 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -89.93%.

However, within the Healthcare sector 718 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from to 4169.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter	(Mar 31 2025) IV. Quarter
Y / Y Total Assets Change	42 %	5.01 %	-28.23 %	-6.04 %	-25.02 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-9	-7	-6	-6	-7
Return On Assets (TTM)	-89.93 %	-78.84 %	-73.3 %	-65.7 %	-72.59 %
IGC's Total Ranking	# 4169	#	# 4213	# 4264	# 4364
Total Assets (TTM) in million	11	9	9	10	8
Seq. Total Assets Change	22.8 %	5.01 %	-10.22 %	22.66 %	-9.19 %
Seq. Net Income Change	-	-	-	-	-

IGC's 5 Years Annual ROA >> Back to IGC Management Effectiveness >> Compare IGC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 330
Sector	# 719
Overall	# 4190

Return On Assets Statistics
High	Average	Low
-9.69 %	-36.32 %	-104.65 %
(Mar 31 2013)		(Sep 30 2024)

Financial Statements
Igc Pharma Inc 's Assets	$ 11 million	IGC's Balance sheet
Igc Pharma Inc 's Income	$ -3 million	Quarterly IGC's Income Statement
IGC's Income by Division		See IGC's Income by Division

Annual Return On Assets	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022	(Mar 31 2021) FY 2021
Y / Y Total Assets Change	-28.23 %	-29.05 %	-35.98 %	-25.18 %	23.75 %
Total Assets in million	9	12	17	27	36
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-7	-13	-12	-15	-9
Annual Return On Assets	-81.41 %	-106.67 %	-66.98 %	-55.96 %	-24.57 %

IGC's 5 Years Annual ROA >> Back to IGC Management Effectiveness >> Compare IGC ROA to its Competitors

More Return On Assets Ratios
IGC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IGC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IGC's Competitors
Subscribers only: Roa for Igc Pharma Inc 's Suppliers
Subscribers only: Return On Assets for IGC's Customers

You may also want to know
IGC's Roi	IGC's Inventory Turnover Ratio	IGC's Growth Rates	IGC's Dividend Comparisons
	IGC's Profitability Ratios	IGC's Asset Turnover Ratio	IGC's Dividend Growth
IGC's Roe	IGC's Valuation Ratios	IGC's Financial Strength Ratios	IGC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-16T08:24:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.